Cargando…
Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study
BACKGROUND: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results. METHODS: We conducted a matched case–control study with 31 cases and 93 cont...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266216/ https://www.ncbi.nlm.nih.gov/pubmed/25490897 http://dx.doi.org/10.1186/s12879-014-0650-9 |
_version_ | 1782348991096160256 |
---|---|
author | Willmann, Matthias Klimek, Anna M Vogel, Wichard Liese, Jan Marschal, Matthias Autenrieth, Ingo B Peter, Silke Buhl, Michael |
author_facet | Willmann, Matthias Klimek, Anna M Vogel, Wichard Liese, Jan Marschal, Matthias Autenrieth, Ingo B Peter, Silke Buhl, Michael |
author_sort | Willmann, Matthias |
collection | PubMed |
description | BACKGROUND: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results. METHODS: We conducted a matched case–control study with 31 cases and 93 controls (1:3). Cases were colonised with XDR-PA during hospitalisation. Independent risk factors were determined using a three step conditional logistic regression procedure. A CRS was built with respect to the corresponding risk fraction of each risk factor, and its discriminatory power was estimated by receiver operating characteristic (ROC) analysis. RESULTS: The presence of a central venous catheter (OR 7.41, P = 0.0008), the presence of a urinary catheter (OR 21.04, P < 0.0001), CRP > 10 mg/dl (OR 7.36, P = 0.0015), and ciprofloxacin administration (OR 5.53, P = 0.025) were independent risk factors. The CRS exhibited a high discriminatory power, defining a high risk population with an approximately fourteen times greater risk for XDR-PA colonisation. CONCLUSIONS: Unnecessary use of antibiotics, particularly ciprofloxacin should be avoided, and a high standard of infection control measures must be achieved when using medical devices. A CRS can be used for adaptation of the active screening culture policy to the local setting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0650-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4266216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42662162014-12-16 Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study Willmann, Matthias Klimek, Anna M Vogel, Wichard Liese, Jan Marschal, Matthias Autenrieth, Ingo B Peter, Silke Buhl, Michael BMC Infect Dis Research Article BACKGROUND: This study aimed to investigate risk factors for colonisation with extensively drug-resistant P. aeruginosa (XDR-PA) in immunocompromised patients and to build a clinical risk score (CRS) based on these results. METHODS: We conducted a matched case–control study with 31 cases and 93 controls (1:3). Cases were colonised with XDR-PA during hospitalisation. Independent risk factors were determined using a three step conditional logistic regression procedure. A CRS was built with respect to the corresponding risk fraction of each risk factor, and its discriminatory power was estimated by receiver operating characteristic (ROC) analysis. RESULTS: The presence of a central venous catheter (OR 7.41, P = 0.0008), the presence of a urinary catheter (OR 21.04, P < 0.0001), CRP > 10 mg/dl (OR 7.36, P = 0.0015), and ciprofloxacin administration (OR 5.53, P = 0.025) were independent risk factors. The CRS exhibited a high discriminatory power, defining a high risk population with an approximately fourteen times greater risk for XDR-PA colonisation. CONCLUSIONS: Unnecessary use of antibiotics, particularly ciprofloxacin should be avoided, and a high standard of infection control measures must be achieved when using medical devices. A CRS can be used for adaptation of the active screening culture policy to the local setting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-014-0650-9) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-10 /pmc/articles/PMC4266216/ /pubmed/25490897 http://dx.doi.org/10.1186/s12879-014-0650-9 Text en © Willmann et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Willmann, Matthias Klimek, Anna M Vogel, Wichard Liese, Jan Marschal, Matthias Autenrieth, Ingo B Peter, Silke Buhl, Michael Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study |
title | Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study |
title_full | Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study |
title_fullStr | Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study |
title_full_unstemmed | Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study |
title_short | Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study |
title_sort | clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant pseudomonas aeruginosa in a haematological patient population: a matched case control study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266216/ https://www.ncbi.nlm.nih.gov/pubmed/25490897 http://dx.doi.org/10.1186/s12879-014-0650-9 |
work_keys_str_mv | AT willmannmatthias clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT klimekannam clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT vogelwichard clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT liesejan clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT marschalmatthias clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT autenriethingob clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT petersilke clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy AT buhlmichael clinicalandtreatmentrelatedriskfactorsfornosocomialcolonisationwithextensivelydrugresistantpseudomonasaeruginosainahaematologicalpatientpopulationamatchedcasecontrolstudy |